Breaking News Instant updates and real-time market news.

CORI

Corium

$7.25

-0.22 (-2.95%)

16:08
08/09/18
08/09
16:08
08/09/18
16:08

Corium reports Q3 EPS (34c), consensus (38c)

Reports Q3 revenue $7.7M, consensus $7.51M. Cash and cash equivalents as of June 30 were $82.5M.

  • 09

    Aug

CORI Corium
$7.25

-0.22 (-2.95%)

12/26/17
NEED
12/26/17
NO CHANGE
Target $14
NEED
Buy
Corium price target lowered to $14 from $16 at Needham
Needham analyst Serge Belanger lowered his price target on Corium (CORI) to $14 after the FDA's letter on the Twirla contraceptive patch by Agile Therapeutics (AGRX) outlined its deficiencies. Belanger says Twirla was Corium's most near-term revenue opportunity, pushing out its anticipated approval by about 12 months. The analyst keeps his Buy rating on Corium.
12/26/17
JEFF
12/26/17
NO CHANGE
Target $13
JEFF
Buy
Corium's partner's CRL looks addressable, says Jefferies
Jefferies analyst David Steinberg believes the complete repose letter received by Corium's (CORI) partner Agile Therapeutics (AGRX) appears addressable. Management indicated the issues relate to Agile's use of standard square-patch tests to assess its circular patch, Steinberg tells investors in a research note. They believe the adhesion profile is "excellent" and, importantly, data addressing the issue has not yet been reviewed by the FDA, the analyst adds. He notes that Twirla's profitability impact to Corium is relatively low, causing only a modest reduction in out-year estimates from the delayed approval. Steinberg keeps a Buy rating on Corium with a $13 price target.
12/27/17
HCWC
12/27/17
NO CHANGE
Target $14
HCWC
Buy
Corium partner's CRL not 'thesis buster,' says H.C. Wainwright
H.C. Wainwright analyst Oren Livnat says while the complete response letter received by partner Agile Therapeutics (AGRX) is a negative surprise and a delay to Corium's (CORI) nearest-term revenue driver, it is "not a thesis buster." The issues raised in the CRL are not deal breakers for Twirla, and will likely just delay approval by one year, Livnat tells investors in a research note. He lowered his price target for Corium shares to $14 from $15 but reiterates a Buy rating on the name.
05/15/18
HCWC
05/15/18
NO CHANGE
Target $14
HCWC
Buy
Corium recent pullback overdone, says H.C. Wainwright
H.C. Wainwright analyst Oren Livnat views the recent pullback in shares of Corium International (CORI) as overdone and unwarranted. The stock is down 30% since the company's recapitalization at the end of February, which "is a bit of a mystery," Livnat tells investors in a research note. The analyst is not aware of any negative fundamental developments for the key pipeline driver, a weekly donepezil patch for Alzheimer's, or any material updates to its partner Agile's (AGRX) Twirla contraceptive patch. He reiterates a Buy rating on Corium with a $14 price target.

TODAY'S FREE FLY STORIES

LYB

LyondellBasell

$82.34

-1.35 (-1.61%)

05:16
12/17/18
12/17
05:16
12/17/18
05:16
Upgrade
LyondellBasell rating change  »

LyondellBasell upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EC

Ecopetrol

$18.36

-0.33 (-1.77%)

, YPF

YPF

$14.38

0.03 (0.21%)

05:11
12/17/18
12/17
05:11
12/17/18
05:11
Recommendations
Ecopetrol, YPF, Petrobras analyst commentary  »

Ecopetrol price target…

EC

Ecopetrol

$18.36

-0.33 (-1.77%)

YPF

YPF

$14.38

0.03 (0.21%)

PBR

Petrobras

$13.40

-0.235 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALK

Alaska Air

$62.29

0.96 (1.57%)

05:04
12/17/18
12/17
05:04
12/17/18
05:04
Recommendations
Alaska Air analyst commentary  »

Alaska Air called a top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVYA

Avaya

$17.58

-0.14 (-0.79%)

04:59
12/17/18
12/17
04:59
12/17/18
04:59
Initiation
Avaya initiated  »

Avaya initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGX

Argenx

$102.30

-0.94 (-0.91%)

04:57
12/17/18
12/17
04:57
12/17/18
04:57
Initiation
Argenx initiated  »

Argenx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORTX

Orchard Therapeutics

$15.00

-0.01 (-0.07%)

04:56
12/17/18
12/17
04:56
12/17/18
04:56
Upgrade
Orchard Therapeutics rating change  »

Orchard Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHW

Sherwin-Williams

$385.73

-0.075 (-0.02%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Upgrade
Sherwin-Williams rating change  »

Sherwin-Williams upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACHN

Achillion

$3.12

0.035 (1.14%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Achillion to hold a conference call »

Dr. Stephen Zelenkofske,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

MDP

Meredith

$53.26

-0.54 (-1.00%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Meredith management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

EQH

AXA Equitable

$16.87

-0.67 (-3.82%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
AXA Equitable to hold a conference call »

Investor Conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

AEYE

AudioEye

$6.99

-0.09 (-1.27%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
AudioEye management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

TLRA

Telaria

$2.81

-0.02 (-0.71%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Telaria management to meet with Lake Street »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

CSCO

Cisco

$45.80

-1.66 (-3.50%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
UBS to host a conference call with Cisco »

UBS IT Hardware Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 10

    Jan

  • 04

    Mar

MGPI

MGP Ingredients

$56.54

0.05 (0.09%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
MGP Ingredients management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
UBS retail/hardlines analyst to hold an analyst/industry conference call »

Retail/Hardlines Analyst…

EFX

Equifax

$97.19

0.07 (0.07%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Equifax to meet with investors »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

04:55
12/17/18
12/17
04:55
12/17/18
04:55
General news
Housing Market Index to be reported at 10:00 »

December Housing Market…

04:55
12/17/18
12/17
04:55
12/17/18
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

VNDA

Vanda Pharmaceuticals

$26.26

0.11 (0.42%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Cantor Fitzgerald biotech analyst to hold an analyst/industry conference call »

Biotech Analyst Duncan,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

CSTM

Constellium

$7.71

-0.7 (-8.32%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Constellium management to meet with Morgan Stanley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

EXC

Exelon

$47.07

0.11 (0.23%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Exelon management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

GNRC

Generac

$52.13

-1.39 (-2.60%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Generac management to meet with KeyBanc »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

IPGP

IPG Photonics

$117.95

-2.28 (-1.90%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
IPG Photonics management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

04:55
12/17/18
12/17
04:55
12/17/18
04:55
General news
Empire State Mfg Survey General Business Conditions Index to be reported at 08:30 »

December Empire State Mfg…

04:55
12/17/18
12/17
04:55
12/17/18
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.